市場調査レポート
商品コード
1093671

創薬向け人工知能 (AI) の世界市場の分析 (2022年~2032年):提供製品/サービス別 (AIソフトウェア/サービス)・技術別・用途別・種類別の予測、地域別・主要国の分析、主要企業、新型コロナウイルス感染症 (COVID-19) からの回復シナリオ

Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032: Forecasts by Offering (AI Software/Services), by Technology, by Applications, by Type, Regional & Leading National Market Analysis, Leading Companies, COVID-19 Recovery Scenarios

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 461 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=195.22円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

創薬向け人工知能 (AI) の世界市場の分析 (2022年~2032年):提供製品/サービス別 (AIソフトウェア/サービス)・技術別・用途別・種類別の予測、地域別・主要国の分析、主要企業、新型コロナウイルス感染症 (COVID-19) からの回復シナリオ
出版日: 2022年06月14日
発行: Visiongain Reports Ltd.
ページ情報: 英文 461 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬向け人工知能 (AI) の市場規模は、2022年に9億1,900万米ドル以上に達する見通しです。更に、2032年まで力強い収益成長が予測されます。

当レポートでは、世界の創薬向け人工知能 (AI) の市場について分析し、市場の基本構造・背景事情や最新情勢、主な促進・抑制要因、市場規模の推定値・予測値 (2022年~2032年)、提供製品/サービス別・技術別・用途別・種類別および地域別・主要国の詳細動向、主要企業のプロファイル、COVID-19の影響と回復シナリオ、といった情報を取りまとめてお届けいたします。

目次

第1章 分析概要

第2章 エグゼクティブサマリー

第3章 創薬向け人工知能 (AI) の産業構造

  • 概要
  • 業界のバリューチェーン分析
  • 人工知能 (AI) による創薬の変革
  • AIのためのネットワークとツール
  • 医薬品ライフサイクルにおけるAI
  • 創薬におけるAI
    • 薬剤設計におけるAI
    • ポリファーモコロジー (多重薬理学) におけるAI
    • 化学合成におけるAI
    • ドラッグリポジショニング (既存薬再開発) におけるAI
    • 薬物スクリーニングにおけるAI
  • 薬物スクリーニングにおけるAI
  • 薬物分子の設計におけるAI
  • 医薬品開発の推進におけるAI
  • 製剤製造におけるAI

第4章 世界市場の力学

  • 市場促進要因
  • 市場抑制要因
  • 世界市場の機会
  • 世界市場の課題
  • 世界市場のSWOT分析
  • 世界市場のPEST分析
  • ポーターのファイブフォース分析

第5章 世界の創薬向け人工知能 (AI) 市場の分析

  • 世界市場の展望

第6章 世界の創薬向け人工知能 (AI) 市場の予測 (2022年~2032年)

  • 世界の創薬向け人工知能 (AI) 市場:地域別
  • 世界の創薬向け人工知能 (AI) 市場:提供製品/サービス別
  • 世界の創薬向け人工知能 (AI) 市場:技術別
  • 世界の創薬向け人工知能 (AI) 市場:用途別
  • 世界の創薬向け人工知能 (AI) 市場:種類別

第7章 北米の創薬向け人工知能 (AI) 市場

  • 北米市場の見通し
  • 米国市場
  • カナダ市場
  • メキシコ市場
  • 北米の創薬向け人工知能 (AI) 市場:国別
  • 北米の創薬向け人工知能 (AI) 市場:提供製品/サービス別
  • 北米の創薬向け人工知能 (AI) 市場:技術別
  • 北米の創薬向け人工知能 (AI) 市場:用途別

第8章 欧州の創薬向け人工知能 (AI) 市場

  • 欧州市場の見通し
  • ドイツ市場
  • 英国市場
  • フランス市場
  • イタリア市場
  • スペイン市場
  • 他の欧州諸国の市場
  • 欧州の創薬向け人工知能 (AI) 市場:国別
  • 欧州の創薬向け人工知能 (AI) 市場:提供製品/サービス別
  • 欧州の創薬向け人工知能 (AI) 市場:技術別
  • 欧州の創薬向け人工知能 (AI) 市場:用途別
  • 欧州の創薬向け人工知能 (AI) 市場:種類別

第9章 アジア太平洋の創薬向け人工知能 (AI) 市場

  • アジア太平洋市場の見通し
  • 中国市場
  • インド市場
  • 日本市場
  • 韓国市場
  • オーストラリア市場
  • 他のアジア太平洋諸国の市場
  • アジア太平洋の創薬向け人工知能 (AI) 市場:国別
  • アジア太平洋の創薬向け人工知能 (AI) 市場:提供製品/サービス別
  • アジア太平洋の創薬向け人工知能 (AI) 市場:技術別
  • アジア太平洋の創薬向け人工知能 (AI) 市場:用途別
  • アジア太平洋の創薬向け人工知能 (AI) 市場:種類別

第10章 ラテンアメリカ・中東・アフリカの創薬向け人工知能 (AI) 市場

  • ラテンアメリカ・中東・アフリカ市場の見通し
  • ブラジル市場
  • トルコ市場
  • サウジアラビア市場
  • 南アフリカ市場
  • アラブ首長国連邦 (UAE) 市場
  • 他のラテンアメリカ・中東・アフリカ諸国の市場
  • ラテンアメリカ・中東・アフリカの創薬向け人工知能 (AI) 市場:国別
  • ラテンアメリカ・中東・アフリカの創薬向け人工知能 (AI) 市場:提供製品/サービス別
  • ラテンアメリカ・中東・アフリカの創薬向け人工知能 (AI) 市場:技術別
  • ラテンアメリカ・中東・アフリカの創薬向け人工知能 (AI) 市場:用途別
  • ラテンアメリカ・中東・アフリカの創薬向け人工知能 (AI) 市場:種類別

第11章 大手企業の分析とプロファイル

  • Atomwise
    • スナップショット
    • 会社概要
    • 製品のベンチマーク
    • 近年の動向
  • Benevolent AI
  • Berg Health
  • Bioage
  • Biosymetrics
  • Cloud Pharmaceuticals
  • Cyclica
  • Deep Genomics
  • DeepMind
  • Envisagenics
  • Euretos
  • Exscientia
  • GNS Healthcare
  • IBM Corporation
  • Insilico Medicine

第12章 結論と提言

第13章 用語集

図表

List of Tables

  • Table 1: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 2: Global Artificial Intelligence (AI) in Drug Discovery Market Snapshot, 2022 & 2032 (US$million, CAGR %)
  • Table 3: Artificial Intelligence (AI) in Drug Discovery Swot Analysis
  • Table 4: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 5: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 6: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 7: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 8: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 9: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 10: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 11: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 12: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 13: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 14: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 15: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 16: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 17: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 18: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 19: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 20: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 21: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 22: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 23: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 24: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 25: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 26: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 27: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 28: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 29: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 30: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 31: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 32: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 33: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 34: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 35: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 36: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 37: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 38: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 39: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 40: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 41: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 42: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 43: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 44: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 45: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 46: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 47: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 48: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 49: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 50: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 51: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 52: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 53: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 54: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 55: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 56: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 57: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 58: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 59: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 60: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 61: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 62: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 63: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 64: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 65: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 66: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 67: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 68: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 69: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 70: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 71: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 72: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 73: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 74: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 75: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 76: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 77: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 78: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 79: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 80: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 81: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 82: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 83: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 84: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 85: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 86: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 87: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 88: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 89: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 90: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 91: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 92: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 93: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 94: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 95: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 96: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 97: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 98: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 99: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 100: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 101: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 102: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 103: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 104: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 105: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 106: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 107: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 108: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 109: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 110: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 111: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 112: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 113: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 114: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 115: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 116: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 117: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 118: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 119: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 120: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 121: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 122: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 123: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 124: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 125: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 126: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 127: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 128: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 129: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 130: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 131: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 132: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 133: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 134: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 135: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 136: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 137: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 138: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 139: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 140: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 141: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 142: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 143: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 144: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 145: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 146: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 147: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 148: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 149: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 150: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 151: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 152: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 153: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 154: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 155: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 156: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 157: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 158: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 159: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 160: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 161: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 162: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 163: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 164: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 165: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 166: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 167: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 168: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 169: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 170: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 171: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 172: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 173: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 174: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 175: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 176: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 177: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 178: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 179: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 180: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 181: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 182: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 183: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 184: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 185: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 186: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 187: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 188: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 189: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 190: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 191: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 192: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 193: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 194: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 195: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 196: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 197: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 198: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 199: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 200: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 201: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 202: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 203: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 204: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 205: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 206: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 207: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 208: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 209: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 210: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 211: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 212: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 213: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 214: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 215: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 216: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 217: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 218: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 219: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 220: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 221: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 222: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 223: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 224: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 225: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 226: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 227: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 228: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 229: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 230: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 231: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 232: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 233: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 234: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%))
  • Table 235: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (V-Shaped Recovery Scenario)
  • Table 236: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (W-Shaped Recovery Scenario)
  • Table 237: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (U-Shaped Recovery Scenario)
  • Table 238: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%), CAGR(%)) (L-Shaped Recovery Scenario)
  • Table 239: Atomwise: Company Information
  • Table 240: Atomwise: Company Product and Service Benchmarking
  • Table 241: Atomwise: Company Recent Developments
  • Table 242: Benevolent AI: Company Information
  • Table 243: Benevolent AI: Company Product and Service Benchmarking
  • Table 244: KKK: Company Recent Developments
  • Table 245: Berg Health: Company Information
  • Table 246: Berg Health: Company Product and Service Benchmarking
  • Table 247: Berg Health: Company Recent Developments
  • Table 248: Bioage: Company Information
  • Table 249: Bioage: Company Product and Service Benchmarking
  • Table 250: Bioage: Company Recent Developments
  • Table 251: Biosymetrics: Company Information
  • Table 252: Biosymetrics: Company Product and Service Benchmarking
  • Table 253: Cloud Pharmaceuticals: Company Information
  • Table 254: Cloud Pharmaceuticals:: Company Product and Service Benchmarking
  • Table 255: Cyclica: Company Information
  • Table 256: Cyclica: Company Product and Service Benchmarking
  • Table 257: Cyclica: Company Recent Developments
  • Table 258: Deep Genomics: Company Information
  • Table 259: Deep Genomics: Company Product and Service Benchmarking
  • Table 260: Deep Genomics: Company Recent Developments
  • Table 261: DeepMind: Company Information
  • Table 262: DeepMind: Company Product and Service Benchmarking
  • Table 263: Deepmind: Company Recent Developments
  • Table 264: Envisagenics: Company Information
  • Table 265: Envisagenics: Company Product and Service Benchmarking
  • Table 266: Envisagenics: Company Recent Developments
  • Table 267: Euretos: Company Information
  • Table 268: Euretos: Company Product and Service Benchmarking
  • Table 269: Euretos: Company Recent Developments
  • Table 270: Exscientia: Company Information
  • Table 271: Exscientia: Company Product and Service Benchmarking
  • Table 272: Exscientia: Company Recent Developments
  • Table 273: GNS Healthcare: Company Information
  • Table 274: GNS Healthcare: Company Product and Service Benchmarking
  • Table 275: GNS Healthcare: Company Recent Developments
  • Table 276: IBM Corporation: Company Information
  • Table 277: IBM Corporation: Company Revenue 2017-2021 (US$Mn, AGR %)
  • Table 278: IBM Corporation: Company Product and Service Benchmarking
  • Table 279: IBM Corporation: Company Recent Developments
  • Table 280: Insilico Medicine: Company Information
  • Table 281: Insilico Medicine: Company Product and Service Benchmarking
  • Table 282: Insilico Medicine: Company Recent Developments

List of Figures

  • Figure 1: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%))
  • Figure 2: Global Artificial Intelligence (AI) in Drug Discovery Market Segmentation
  • Figure 3: Artificial Intelligence (AI) in Drug Discovery PEST Analysis
  • Figure 4: Artificial Intelligence (AI) in Drug Discovery Porter's Five Forces.
  • Figure 5: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%))
  • Figure 6: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 7: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 8: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 9: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 10: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%))
  • Figure 11: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 12: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 13: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 14: Global Artificial Intelligence (AI) in Drug Discovery Market by Region, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 15: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
  • Figure 16: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 17: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 18: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 19: Global Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 20: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
  • Figure 21: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 22: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 23: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 24: Global Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 25: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
  • Figure 26: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 27: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 28: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 29: Global Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 30: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
  • Figure 31: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 32: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 33: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 34: Global Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 35: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 36: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 37: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 38: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 39: North America Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 40: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 41: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 42: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 43: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 44: US Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 45: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 46: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 47: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 48: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 49: Canada Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 50: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 51: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 52: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 53: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 54: Mexico Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 55: North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
  • Figure 56: North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 57: North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 58: North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 59: North America Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 60: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
  • Figure 61: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 62: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 63: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 64: North America Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 65: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
  • Figure 66: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 67: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 68: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 69: North America Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 70: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
  • Figure 71: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 72: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 73: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 74: North America Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 75: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
  • Figure 76: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 77: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 78: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 79: North America Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 80: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 81: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 82: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 83: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 84: Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 85: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 86: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 87: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 88: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 89: Germany Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 90: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 91: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 92: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 93: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 94: UK Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 95: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 96: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 97: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 98: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 99: France Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 100: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 101: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 102: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 103: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 104: Italy Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 105: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 106: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 107: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 108: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 109: Spain Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 110: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 111: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 112: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 113: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 114: Rest of Europe Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 115: Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
  • Figure 116: Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 117: Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 118: Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 119: Europe Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 120: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
  • Figure 121: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 122: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 123: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 124: Europe Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 125: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
  • Figure 126: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 127: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 128: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 129: Europe Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 130: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
  • Figure 131: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 132: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 133: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 134: Europe Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 135: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
  • Figure 136: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 137: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 138: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 139: Europe Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 140: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 141: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 142: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 143: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 144: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 145: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 146: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 147: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 148: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 149: China Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 150: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 151: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 152: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 153: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 154: India Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 155: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 156: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 157: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 158: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 159: Japan Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 160: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 161: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 162: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 163: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 164: South Korea Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 165: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 166: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 167: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 168: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 169: Australia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 170: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 171: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 172: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 173: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 174: Rest of Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 175: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
  • Figure 176: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 177: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 178: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 179: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 180: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
  • Figure 181: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 182: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 183: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 184: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 185: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
  • Figure 186: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 187: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 188: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 189: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 190: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
  • Figure 191: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 192: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 193: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 194: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 195: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
  • Figure 196: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 197: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 198: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 199: Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 200: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 201: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 202: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 203: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 204: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 205: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 206: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 207: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 208: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 209: Brazil Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 210: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 211: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 212: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 213: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 214: Turkey Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 215: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 216: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 217: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 218: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 219: Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 220: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 221: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 222: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 223: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 224: South Africa Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 225: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 226: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 227: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 228: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 229: UAE Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 230: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%))
  • Figure 231: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 232: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 233: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 234: Rest of LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Value, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 235: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%))
  • Figure 236: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 237: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 238: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 239: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Country, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 240: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%))
  • Figure 241: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 242: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 243: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 244: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Offering, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 245: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%))
  • Figure 246: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 247: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 248: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 249: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Technology, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 250: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%))
  • Figure 251: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 252: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 253: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 254: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Applications, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 255: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%))
  • Figure 256: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (V-Shaped Recovery Scenario)
  • Figure 257: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (W-Shaped Recovery Scenario)
  • Figure 258: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (U-Shaped Recovery Scenario)
  • Figure 259: LAMEA Artificial Intelligence (AI) in Drug Discovery Market by Type, 2022-2032 (USD Mn, AGR (%)) (L-Shaped Recovery Scenario)
  • Figure 260: IBM Corporation: Company Revenue 2017-2021 (US$Mn, AGR %)
  • Figure 261: AMCOR LTD: Company Operating Income 2017-2021 (US$Mn, AGR %)
  • Figure 262: IBM Corporation: Company Net Income 2017-2021 (US$Mn, AGR %)
  • Figure 263: IBM Corporation: Company EBITDA 2017-2021 (US$Mn, AGR %)
  • Figure 264: Global Artificial Intelligence (AI) in Drug Discovery Market Forecast by Artificial Intelligence (AI) in Drug Discovery 2022, 2027, 2032 (%)

List of Companies Profiled in the report:

  • Atomwise
  • Benevolent AI
  • Berg Health
  • Bioage
  • Biosymetrics
  • Cloud Pharmaceuticals
  • Cyclica
  • Deep Genomics
  • DeepMind
  • Envisagenics
  • Euretos
  • Exscientia
  • GNS Healthcare
  • IBM Corporation
  • Insilico Medicine

List of Other Companies Mentioned in the report:

  • Accenture
  • AdventHealth
  • AstraZeneca
  • ATAI Lifesciences AG
  • Bayer
  • BioMarin Pharmaceuticals, Inc.
  • BioMotiv
  • Blue Oak Pharmaceuticals
  • Boehringer Ingelheim
  • Bridge Biotherapeutics
  • Bristol Myers Squibb
  • Celgene
  • Cereval Therapeutics
  • Charles River Laboratories
  • Datavant
  • Deutsche Telekom
  • Diamond Light Source
  • DNDi
  • Eli Lilly and Company
  • Elsevier
  • Enamine, Ltd.
  • Eurofarma
  • Excelra
  • FMC Corporation
  • Gilead Sciences, Inc.
  • GitHub, Inc.
  • GlaxoSmithKline
  • Google, Inc.
  • GT Apeiron Therapeutics
  • Gustave Roussy
  • Hansoh Pharmaceutical Group Company Limited
  • Haystack Sciences
  • HollandBIO
  • Huadong Medicine
  • Instana
  • Janssen
  • Mannin Research
  • NeuroTheryX Canada, Ltd.
  • Novartis
  • Nuance Communications, Inc.
  • NYU Langone Health
  • Pfizer
  • Rallybio
  • Red Hat, Inc.
  • Roche
  • Sema4
  • ServiceNow
  • Sophia Genetics
  • SRI International
  • Sumitomo Dainippon Pharma
  • Temasek
  • UnitedHealth Group
  • Wave Life Sciences, Ltd.
  • WuXi AppTec
  • Zeiss Group

List of Associations Mentioned in the Report:

  • Alliance for Clinical Trials in Oncology
  • Bill & Melinda Gates Foundation
  • Brigham and Women's Hospital
  • Cancer Research UK Imperial Centre
  • CINECA
  • Duke University
  • FedDev Ontario
  • Genome Institute
  • Harvard Medical School
  • Institut Carnot CALYM
  • Merck Global Health Innovation Fund
  • Multiple Myeloma Research Foundation
  • U-M Life Sciences Institute
  • University of California
  • University of Michigan College of Pharmacy
  • University of Pittsburgh
  • Vanderbilt University Medical Center
  • World Health Organization
目次
Product Code: PHA1172

Title:
Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032
Forecasts by Offering (AI Software, AI Services), by Technology (Deep Learning, Supervised Learning, Reinforcement Learning, Unsupervised Learning, Other), by Applications (Oncology, Infectious Diseases, Neurological Disorders, Metabolic Diseases, Cardiovascular Diseases, Other), by Type (Target Identification, Molecule Screening, Drug Design and Drug Optimisation, Preclinical and Clinical Testing) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

The Artificial Intelligence (AI) in Drug Discovery Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The Rising Adoption of Cloud-Based Applications & Services Is Driving the Market

Artificial intelligence (AI) is defined as a machine that employs modern technology to do tasks that are similar to those performed by the human mind. The primary purpose of drug discovery research is to find medications that can aid in the prevention or treatment of specific diseases. The difficulties of reviewing, obtaining, and utilising data to solve difficult medical problems fueled demand for artificial intelligence (AI) in the drug discovery business. The market for artificial intelligence in drug development is divided into offering, technology, type, applications, and region. The growing number of cross-industry collaborations and partnerships, the increasing need to control drug discovery & development costs and reduce overall time taken in this process, the rising adoption of cloud-based applications & services, and the impending patent expiration of blockbuster drugs are all driving the artificial intelligence in drug discovery market. On the other side, the market's expansion is being hampered by a paucity of data sets in the field of drug discovery and an insufficient supply of competent workers.

The Lack of Data Is a Recurring Problem Throughout All Industries Implementing AI

The shortage of data is a reoccurring issue in all industries that are deploying AI. A standard biological investigation requires a minimum of five samples to be legitimate. Meanwhile, in order to function well, most machine learning algorithms must be trained on hundreds of thousands of data points or samples. This is why obtaining high-quality healthcare data is critical something that has proven increasingly challenging over time. The challenge is due to the disorganised and fragmented health data scattered across many data platforms and organisations. Patients' insurance and healthcare providers change too frequently, making data collection difficult.

What Are These Questions You Should Ask Before Buying A Market Research Report?

  • How is the artificial intelligence (AI) in drug discovery market evolving?
  • What is driving and restraining the artificial intelligence (AI) in drug discovery market?
  • How will each artificial intelligence (AI) in drug discovery submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
  • How will the market shares for each artificial intelligence (AI) in drug discovery submarket develop from 2022 to 2032?
  • What will be the main driver for the overall market from 2022 to 2032?
  • Will leading artificial intelligence (AI) in drug discovery markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the artificial intelligence (AI) in drug discovery projects for these leading companies?
  • How will the industry evolve during the period between 2020 and 2032?What are the implication of artificial intelligence (AI) in drug discovery projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the artificial intelligence (AI) in drug discovery market?
  • Where is the artificial intelligence (AI) in drug discovery market heading? And how can you ensure you are at the forefront of the market?
  • What can be the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path? C-suite?

You need to discover how this will impact the artificial intelligence (AI) in drug discovery market today, and over the next 10 years:

  • Our 461-page report provides 270 tables and 264 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • Contains in-depth analyse of global, regional and national sales and growth
  • Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the artificial intelligence (AI) in drug discovery market will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising artificial intelligence (AI) in drug discovery prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, V, L, W and U are discussed in this report.

Segments Covered in this report:

Market Segment by Offering

  • AI Software
  • AI Services

Market Segment by Technology

  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Technology

Market Segment by Applications

  • Oncology
  • Infectious Diseases
  • Neurological Disorders
  • Metabolic Diseases
  • Cardiovascular Diseases
  • Other Applications

Market Segment by Type

  • Target Identification
  • Molecule Screening
  • Drug Design and Drug Optimization
  • Preclinical and Clinical Testing

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 4 regional and 20 leading national markets:

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

LAMEA

  • Brazil
  • Turkey
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Latin America, Middle East and Africa

The report also includes profiles and for some of the leading companies in the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Atomwise
  • Benevolent AI
  • Berg Health
  • Bioage
  • Biosymetrics
  • Cloud Pharmaceuticals
  • Cyclica
  • Deep Genomics
  • DeepMind
  • Envisagenics
  • Euretos
  • Exscientia
  • GNS Healthcare
  • IBM Corporation
  • Insilico Medicine

Overall world revenue for Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 in terms of value the market will surpass US$919 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market report helps you?

In summary, our 461-page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market, with forecasts for application, technology, type, offering, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2032 for 4 regional and 20 key national markets - See forecasts for the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 15 of the major companies involved in the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Artificial Intelligence (AI) in Drug Discovery Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Introduction to Artificial Intelligence (AI) in Drug Discovery Market
  • 1.2. Global Artificial Intelligence (AI) in Drug Discovery Market Overview
  • 1.3. What Are the Objectives of this Report?
  • 1.4. What is the Scope of the Report?
  • 1.5. Artificial Intelligence (AI) in Drug Discovery Market Definition
  • 1.6. Why You Should Read this Report
  • 1.7. What this Report Delivers
  • 1.8. Key Questions Answered by this Analytical Report Include:
  • 1.9. Who is this Report for?
  • 1.10. Research Methodology
    • 1.10.1. Primary Research
    • 1.10.2. Secondary Research
    • 1.10.3. Market Evaluation & Forecasting Methodology
  • 1.11. Frequently Asked Questions (FAQs)
  • 1.12. Associated Visiongain Reports
  • 1.13. About Visiongain

2. Executive Summary

3. Artificial Intelligence (AI) in Drug Discovery Industry Structure

  • 3.1. Overview
  • 3.2. Industry Value Chain Analysis
  • 3.3. Artificial Intelligence Is Changing Drug Discovery
  • 3.4. Networks and Tools for AI
  • 3.5. AI in the Pharmaceutical Product Lifecycle
  • 3.6. AI in Drug Discovery
    • 3.6.1. AI in Drug Design
    • 3.6.2. AI in Polypharmocology
    • 3.6.3. AI in Chemical Sythesis
    • 3.6.4. AI in drug repurposing
    • 3.6.5. AI in drug screening
  • 3.7. AI in Drug Screening
  • 3.8. AI in Designing Drug Molecules
  • 3.9. AI in Advancing Pharmaceutical Product Development
  • 3.10. AI in Pharmaceutical Manufacturing

4. Global Market Dynamics

  • 4.1. Market Driving Factors
    • 4.1.1. AI Utilizes the Latest Advances in Biology and Computing to Develop State-of-the-Art Algorithms for Drug Discovery
    • 4.1.2. Thanks to AI, the Cost and Timelines of Developing a New Treatment Will Be Rewritten
    • 4.1.3. Artificial Intelligence (AI) Has Been a Game-Changer for the Pharmaceutical Sector Throughout the Value Chain
  • 4.2. Market Restraining Factors
    • 4.2.1. AI Predictions Are as Good as the Algorithms Used to Investigate a Dataset
    • 4.2.2. AI Can Suffer from Algorithm Bias
    • 4.2.3. Setting Up AI-Based Machines, Computers Entails Huge Costs
  • 4.3. Opportunities in the Global Market
    • 4.3.1. A New Wave of Drug Discovery is Setting the Ideal for the World
    • 4.3.2. AI Has Received a Lot of Attention in the Pharmaceutical Business for Medication Discovery and Development
    • 4.3.3. Understanding the Molecular Causes of a Disease in a Precisely Stratified Patient Sample Is Critical for Drug Discovery Programmes to Hit the Mark and Prevent Late-Stage Effectiveness Failures
  • 4.4. Challenges in the Global Market
    • 4.4.1. The Lack of Data Is a Recurring Problem Throughout All Industries Implementing AI
    • 4.4.2. AI Systems Are Prone to Errors, Which Eventually Leads to a Significant Problems
    • 4.4.3. Another Hindrance in Using AI to Predict Drug Targets Remains to Translate Traditional Basic Research Conducted in Labs Worldwide into a Language That a Computer Can Understand
  • 4.5. Swot Analysis for Global Market
    • 4.5.1. Market Strengths
    • 4.5.2. Market Weakness
    • 4.5.3. Market Opportunites
    • 4.5.4. Market Threats
  • 4.6. PEST Analysis for Global Market
    • 4.6.1. Political Factors
    • 4.6.2. Economic Factors
    • 4.6.3. Social Factors
    • 4.6.4. Technology Factors
  • 4.7. Porter's Five Forces
    • 4.7.1. Threats of New Entrants- High
    • 4.7.2. Bargaining Power of Suppliers- High
    • 4.7.3. Bargaining Power of Buyers- Low
    • 4.7.4. Threats of Substitute - Low
    • 4.7.5. Rivalry among the Existing Competitors - High

5. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis

  • 5.1. Global Market Outlook
    • 5.1.1. Global Artificial Intelligence (AI) in Drug Discovery Market is Expected to Grow at Rapid Pace Due to Huge Drugs Demand
    • 5.1.2. The Adoption of AI Solutions in the Clinical Trial Process Eliminates Various Obstacles

6. Global Artificial Intelligence (AI) in Drug Discovery Market Forecast, 2022-2032

  • 6.1. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Region
  • 6.2. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
  • 6.3. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
  • 6.4. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
  • 6.5. Global Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type

7. North America Artificial Intelligence (AI) in Drug Discovery Market Analysis

  • 7.1. North America Market Outlook
    • 7.1.1. North America Is the Largest Growing Regional Market for AI in Drug Discovery
    • 7.1.2. Postera, a North American Biotechnology Company Specializing in Machine Learning for Preclinical Drug Discovery is Chosen for Further Innovation
  • 7.2. US Artificial Intelligence in Drug Discovery Market Analysis
    • 7.2.1. AI Spending and Funding in US is Getting the Light it Needs
    • 7.2.2. The U.S. Has a Clear Advantage in the Race to Become an AI Superpower
  • 7.3. Canada Artificial Intelligence in Drug Discovery Market Analysis
    • 7.3.1. Canada Offers Resources to Local and Foreign AI-Focused Talent and Organizations
    • 7.3.2. Companies Collaborations and Partnerships in Canada is Accelerating the Usecase of AI in Drug Development
  • 7.4. Mexico Artificial Intelligence (AI) in Drug Discovery Market Analysis
    • 7.4.1. Mexico is One of the First Ten Countries in the World to Adopt an Artificial Intelligence Policy, and it Leads Latin America
    • 7.4.2. Role of Government in Helping to Shape the Development and Uses of AI in Mexico
  • 7.5. North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
  • 7.6. North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
  • 7.7. North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
  • 7.8. North America Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications

8. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis

  • 8.1. Europe Market Outlook
    • 8.1.1. The EU's Approach to Artificial Intelligence Centres on Excellence and Trust, Aiming to Boost Research and Industrial Capacity and Ensure Fundamental Rights
    • 8.1.2. European Proposal for a Legal Framework on AI
  • 8.2. Germany Artificial Intelligence (AI) in Drug Discovery Market Analysis
    • 8.2.1. In Germany, an Algorithm Based on the Brain's Self-Organizing Capacity Has been Developed to Tackle Escalating Medication Development Costs
    • 8.2.2. Germany is at the Forefront of Artificial Intelligence (AI) in Europe
  • 8.3. UK Artificial Intelligence in Drug Discovery Market Analysis
    • 8.3.1. There is Huge Increase in Demand for Ai Professionals in UK
    • 8.3.2. AI could be a significant driver of productivity and GDP growth for the UK economy
  • 8.4. France Artificial Intelligence in Drug Discovery Market Analysis
    • 8.4.1. French Government Supports AI in Healthcare
    • 8.4.2. French Companies Are Coming Together to Find Innovatiove Solutions for Drug Development
  • 8.5. Italy Artificial Intelligence in Drug Discovery Market Analysis
    • 8.5.1. Some Italian Companies Are Now Slowly Beginning to Pilot New Technologies Particularly in AI
    • 8.5.2. Impact of AI on Italy's Economy and Growth
  • 8.6. Spain Artificial Intelligence in Drug Discovery Market Analysis
    • 8.6.1. Impact of AI in Spain
    • 8.6.2. IndesIA is a Spanish Association of Artificial Intelligence for Industry
  • 8.7. Rest of Europe Artificial Intelligence in Drug Discovery Market Analysis
    • 8.7.1. Ireland Has the Highest Share of Businesses Using AI Applications in Europe
    • 8.7.2. European Commission Is Hoping to Set New Oversight Standards in a Bid to Create 'Trustworthy AI'
  • 8.8. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
  • 8.9. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
  • 8.10. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
  • 8.11. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
  • 8.12. Europe Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type

9. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis

  • 9.1. Asia-Pacific Market Outlook
    • 9.1.1. The Growing Startup Culture in Asian Countries Has Also Influenced the Growth of AI, Sspecially in Countries like China and India
    • 9.1.2. Southeast Asia is Still in the Early Stages of AI Adoption
  • 9.2. China Artificial Intelligence in Drug Discovery Market Analysis
    • 9.2.1. Chinese Firms Are Relying on AI to Put More Drugs on the Market, and by Extrapolation Extend Better Services
    • 9.2.2. Chinese Firm Marks the World's First Phase-1 Clinical Trial of a Drug Developed with AI Technology from Scratch
  • 9.3. India Artificial Intelligence in Drug Discovery Market Analysis
    • 9.3.1. Intuition System, a Company from India is Heating up the Game in AI
    • 9.3.2. Other Startups and Companies in India is on the Innovatiove Track Regarding AI in Drug Discovery
  • 9.4. Japan Artificial Intelligence in Drug Discovery Market Analysis
    • 9.4.1. A Powerful New Use for AI in Drug Discovery Has Been Discovered by a Japanese Company
    • 9.4.2. The Pharmaceuticals and Medical Devices Agency (PDMA) Approved 123 New Drug Products in Japan
  • 9.5. South Korea Artificial Intelligence in Drug Discovery Market Analysis
    • 9.5.1. This South Korean Firm Is on the Cutting Edge of AI-Driven Drug Development
    • 9.5.2. South Korea to Use AI in Drug Discovery as the Government Gives Approval
  • 9.6. Australia Artificial Intelligence in Drug Discovery Market Analysis.
    • 9.6.1. Experts from Two Australian University Groups Working on AI in Drug Development Are Supervising the Phd Research
    • 9.6.2. Contribution of Australia in AI in Drug Discovery Research
  • 9.7. Rest of Asia-Pacific Artificial Intelligence in Drug Discovery Market Analysis.
    • 9.7.1. Southeast Asian Countries are also Committing to the Development and Research Involving AI
    • 9.7.2. Singapore's Leading Firm is Taking a Big Leap in AI
  • 9.8. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
  • 9.9. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
  • 9.10. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
  • 9.11. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
  • 9.12. Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Analysis by Type

10. LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis

  • 10.1. LAMEA Market Outlook
    • 10.1.1. Latin America's Growing Artificial Intelligence Wave Can Give Boost to the Low Productivity Countries
    • 10.1.2. AI is Poised to Impact Africa in Several Ways in Drug Discovery
  • 10.2. Brazil Artificial Intelligence in Drug Discovery Market Analysis.
    • 10.2.1. The Brazilian House of Representatives Has Passed a Law that Establishes Legal Guidelines for Artificial Intelligence
    • 10.2.2. Brazil Excels in the Use of Artificial Intelligence
  • 10.3. Turkey Artificial Intelligence in Drug Discovery Market Analysis.
    • 10.3.1. Turkey Plans to Become Among the Top 20 Countries in the International AI Indices
    • 10.3.2. Artificial intelligence (AI) is the New "Oil" of the Near Future and can Provide Huge Opportunities for Turkey
  • 10.4. Saudi Arabia Artificial Intelligence in Drug Discovery Market Analysis.
    • 10.4.1. Saudi Arabia Uses AI in Drug Discovery
    • 10.4.2. Saudi Arabia is Uniquely Placed to Drive Artificial Intelligence Innovation Post-Coronavirus Pandemic
  • 10.5. South Africa Artificial Intelligence in Drug Discovery Market Analysis.
    • 10.5.1. Innovations in South Africa in AI
    • 10.5.2. South Africa to Participate in AI Driven Future in Health and Drug Development Sector
  • 10.6. UAE Artificial Intelligence in Drug Discovery Market Analysis.
    • 10.6.1. The UAE Government launched 'UAE Strategy for Artificial Intelligence (AI)'
    • 10.6.2. Drug Discovery from Artificial Intelligence Partnership Announced In UAE
  • 10.7. Rest of LAMEA Artificial Intelligence in Drug Discovery Market Analysis.
    • 10.7.1. AI's applications in Latin America are already becoming reality in Drug Discovery
    • 10.7.2. AI landscape in sub-Saharan Africa is Improving
  • 10.8. LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Country
  • 10.9. LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Offering
  • 10.10. LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Technology
  • 10.11. LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis by Applications
  • 10.12. LAMEA Artificial Intelligence (AI) in Drug Discovery Market Analysis

11. Leading Company Analysis and Profile

  • 11.1. Atomwise
    • 11.1.1. Company Snapshot
    • 11.1.2. Company Overview
    • 11.1.3. Company Product Benchmarking
    • 11.1.4. Company Recent Developments
  • 11.2. Benevolent AI
    • 11.2.1. Company Snapshot
    • 11.2.2. Company Overview
    • 11.2.3. Company Product Benchmarking
    • 11.2.4. Company Recent Developments
  • 11.3. Berg Health
    • 11.3.1. Company Snapshot
    • 11.3.2. Company Overview
    • 11.3.3. Company Product Benchmarking
    • 11.3.4. Company Recent Developments
  • 11.4. Bioage
    • 11.4.1. Company Snapshot
    • 11.4.2. Company Overview
    • 11.4.3. Company Product Benchmarking
    • 11.4.4. Company Recent Developments
  • 11.5. Biosymetrics
    • 11.5.1. Company Snapshot
    • 11.5.2. Company Overview
    • 11.5.3. Company Product Benchmarking
    • 11.5.4. Company Recent Developments
  • 11.6. Cloud Pharmaceuticals
    • 11.6.1. Company Snapshot
    • 11.6.2. Company Overview
    • 11.6.3. Company Product Benchmarking
  • 11.7. Cyclica
    • 11.7.1. Company Snapshot
    • 11.7.2. Company Overview
    • 11.7.3. Company Product Benchmarking
    • 11.7.4. Company Recent Developments
  • 11.8. Deep Genomics
    • 11.8.1. Company Snapshot
    • 11.8.2. Company Overview
    • 11.8.3. Company Product Benchmarking
    • 11.8.4. Company Recent Developments
  • 11.9. DeepMind
    • 11.9.1. Company Snapshot
    • 11.9.2. Company Overview
    • 11.9.3. Company Product Benchmarking
    • 11.9.4. Company Recent Developments
  • 11.10. Envisagenics
    • 11.10.1. Company Snapshot
    • 11.10.2. Company Overview
    • 11.10.3. Company Product Benchmarking
    • 11.10.4. Company Recent Developments
  • 11.11. Euretos
    • 11.11.1. Company Snapshot
    • 11.11.2. Company Overview
    • 11.11.3. Company Product Benchmarking
    • 11.11.4. Company Recent Developments
  • 11.12. Exscientia
    • 11.12.1. Company Snapshot
    • 11.12.2. Company Overview
    • 11.12.3. Company Recent Developments
  • 11.13. GNS Healthcare
    • 11.13.1. Company Snapshot
    • 11.13.2. Company Overview
    • 11.13.3. Company Product Benchmarking
    • 11.13.4. Company Recent Developments
  • 11.14. IBM Corporation
    • 11.14.1. Company Snapshot
    • 11.14.2. Company Overview
    • 11.14.3. Company Financial Profile
    • 11.14.4. Company Product Benchmarking
    • 11.14.5. Company Recent Developments
  • 11.15. Insilico Medicine
    • 11.15.1. Company Snapshot
    • 11.15.2. Company Overview
    • 11.15.3. Company Product Benchmarking
    • 11.15.4. Company Recent Developments

12. Conclusion and Recommendations

  • 12.1. Conclusion Summary
  • 12.2. Recommendations

13. Glossary Terms

  • 13.1. Associated Visiongain Reports